Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Prepares To Launch LAI Risperidone After US Approval
MedinCell-Partnered Schizophrenia Treatment Uzedy Has Now Been Approved By US FDA
May 02 2023
•
By
David Wallace
The FDA has approved Teva and MedinCell’s LAI risperidone as Uzedy • Source: Shutterstock
More from Products
More from Generics Bulletin